Description
THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
A61P
Technology
Stats
- 26,961 US PATENTS IN FORCE
- 51,053 US APPLICATIONS PENDING
- 15,724 Total Patent Owners
- 225,252 TOTAL INVENTORS
Subclasses
| Subclass | Title |
|---|---|
| 1/00 | Drugs for disorders of the alimentary tract or the digestive system |
| 1/02 | Drugs for disorders of the alimentary tract or the digestive system Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis |
| 1/04 | Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants |
| 1/06 | Drugs for disorders of the alimentary tract or the digestive system Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia |
| 1/08 | Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics |
| 1/10 | Drugs for disorders of the alimentary tract or the digestive system Laxatives |
| 1/12 | Drugs for disorders of the alimentary tract or the digestive system Antidiarrhoeals |
| 1/14 | Drugs for disorders of the alimentary tract or the digestive system Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents |
| 1/16 | Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics |
| 1/18 | Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes |
| 3/00 | Drugs for disorders of the metabolism (of the blood or the extracellular fluid A61P 7/00) |
| 3/02 | Drugs for disorders of the metabolism (of the blood or the extracellular fluid A61P 7/00) Nutrients, e.g. vitamins, minerals |
| 3/04 | Drugs for disorders of the metabolism (of the blood or the extracellular fluid A61P 7/00) Anorexiants; Antiobesity agents |
| 3/06 | Drugs for disorders of the metabolism (of the blood or the extracellular fluid A61P 7/00) Antihyperlipidemics |
| 3/08 | Drugs for disorders of the metabolism (of the blood or the extracellular fluid A61P 7/00) for glucose homeostasis (pancreatic hormones A61P 5/48) |
| 3/10 | Drugs for disorders of the metabolism (of the blood or the extracellular fluid A61P 7/00) for glucose homeostasis (pancreatic hormones A61P 5/48) for hyperglycaemia, e.g. antidiabetics |
| 3/12 | Drugs for disorders of the metabolism (of the blood or the extracellular fluid A61P 7/00) for electrolyte homeostasis |
| 3/14 | Drugs for disorders of the metabolism (of the blood or the extracellular fluid A61P 7/00) for electrolyte homeostasis for calcium homeostasis (vitamin D A61P 3/02; parathyroid hormones A61P 5/18; calcitonin A61P 5/22; osteoporosis A61P 19/1; bone metastasis A61P 35/04) |
| 5/00 | Drugs for disorders of the endocrine system |
| 5/02 | Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin |
Recent Patents
| Patent # | Title | Filing Date | Issue Date | Patent Owner |
|---|---|---|---|---|
| RE50189 | Long term treatment of HIV-infection with TMC278 | Sep 13, 21 | Oct 29, 24 | Janssen Sciences Ireland Unlimited Company |
Recent Publications
| Publication # | Title | Filing Date | Pub Date | Patent Owner |
|---|---|---|---|---|
| 2024/0358,311 | NEURAL NETWORKS FOR ATRIAL FIBRILLATION SCREENING | Jul 10, 24 | Oct 31, 24 | Mayo Foundation for Medical Education and Research |
| 2024/0358,544 | METHOD OF TREATING VISION LOSS IN A HUMAN SUBJECT WITH PHOTOREACTIVE COMPOUNDS | Apr 26, 24 | Oct 31, 24 | Not available |
| 2024/0358,631 | TOPICAL FORMULATIONS | Apr 26, 23 | Oct 31, 24 | Not available |
| 2024/0358,635 | LONG CYCLE-LIFE WOUND LITHIUM-ION BATTERY CELLS HAVING METALLIZED FILM CURRENT COLLECTORS | May 16, 22 | Oct 31, 24 | Not available |
| 2024/0358,639 | NANOPARTICLES FOR CANCER TREATMENT | Jul 07, 22 | Oct 31, 24 | Not available |
| 2024/0358,645 | NOVEL RECOMBINANT EXOSOME CONTAINING HYALURONIDASE AND USE THEREOF | May 01, 24 | Oct 31, 24 | Korea Institute of Science and Technology |
| 2024/0358,652 | LIPID NANOPARTICLE FORMULATIONS | Aug 17, 22 | Oct 31, 24 | Monash University |
| 2024/0358,656 | IMMUNOGENIC COMPOSITION FOR THE TREATMENT OF CANCER AND METHODS OF PREPARING THE SAME | Jun 04, 24 | Oct 31, 24 | Not available |
| 2024/0358,658 | BUPROPION AS A MODULATOR OF DRUG ACTIVITY | Dec 06, 23 | Oct 31, 24 | Not available |
| 2024/0358,659 | Uses of Propranolol for Managing Viral Infections | Aug 30, 22 | Oct 31, 24 | Not available |
| 2024/0358,663 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION | May 07, 24 | Oct 31, 24 | Not available |
| 2024/0358,668 | METHODS AND COMPISITIONS FOR AMELIORATING BIOMARKERS ASSOCIATED WITH CARDIOVASCUALR RISK USING (R)-2-AMINO-3-PHENYLPROPYL CARBAMATE | Sep 02, 22 | Oct 31, 24 | Not available |
| 2024/0358,669 | METHODS FOR TREATING PANCREATIC CANCER | Jul 09, 24 | Oct 31, 24 | Not available |
| 2024/0358,670 | DERIVATIVES OF KORORMICIN USEFUL AS ANTIBIOTICS | Jul 08, 24 | Oct 31, 24 | Not available |
| 2024/0358,671 | COMPOSITIONS AND METHODS TO TREAT SKIN DISORDERS | Sep 07, 22 | Oct 31, 24 | Not available |
| 2024/0358,672 | APPLICATION OF GENISTEIN AND ITS PHOSPHATE ESTER DERIVATIVE AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME | Apr 28, 23 | Oct 31, 24 | Not available |
| 2024/0358,673 | SHORT CHAIN FATTY ACIDS & GALLATES COMPOSITIONS | Oct 06, 23 | Oct 31, 24 | Not available |
| 2024/0358,677 | LASOFOXIFENE TREATMENT OF AROMATASE-RESISTANT ER+ CANCER | Jul 04, 24 | Oct 31, 24 | Not available |
| 2024/0358,678 | METHODS AND COMPOSITIONS FOR ENHANCING CHEMOTHERAPEUTIC DRUG UPTAKE INTO BRAIN TUMORS | Apr 12, 24 | Oct 31, 24 | Not available |
| 2024/0358,679 | PHARMACEUTICAL AND FOOD COMPOSITIONS FOR THE PREVENTION, ALLEVIATION, OR TREATMENT OF INFLAMMATORY DISEASES COMPRISING 1-ALKYL-5-ARYLIDENE-2-SELENOXOIMIDAZOLIDIN-4-ONE AND ITS DERIVATIVES | Jul 10, 24 | Oct 31, 24 | Not available |
Top Owners in This Class
| Upgrade to the Professional Level to view Top Owners for this Class.Learn More |
|---|
Applications Filed in This Class - By Year
Patents Issued To Date - By Filing Year
Average Time to Issuance
- 31 Months (last 2 years Issuances)
- 31 Months (last 5 years Issuances)